Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes.

International hypoglycaemia study group, and Campbell, Matthew (2017) Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes care, 40 (1). pp. 155-157. ISSN 1935-5548

Abstract

Position Statement

The International Hypoglycaemia Study Group recommends that the frequency of detection of a glucose concentration <3.0 mmol/l (<54 mg/dl), which it considers to be clinically significant biochemical hypoglycaemia, be included in reports of clinical trials of glucose-lowering drugs evaluated for the treatment of diabetes mellitus.

Preview

PDF 13136.pdf - Published Version Available under License Creative Commons Attribution. Download (317kB) | Preview

More Information

Depositing User: Matthew Campbell

Identifiers

Item ID: 13136

Identification Number: https://doi.org/10.1007/s00125-016-4146-6

ISSN: 1935-5548

URI: http://sure.sunderland.ac.uk/id/eprint/13136

Official URL: https://link.springer.com/article/10.1007/s00125-0...

Users with ORCIDS

ORCID for Matthew Campbell: orcid.org/0000-0001-5883-5041

Catalogue record

Date Deposited: 01 Mar 2021 09:36

Last Modified: 01 Mar 2021 09:45

Contributors

Author:	Matthew Campbell
Author:	International hypoglycaemia study group

University Divisions

Faculty of Health Sciences and Wellbeing

Actions (login required)

View Item